1 Min Read
Oct 24 (Reuters) - Theratechnologies Inc
* Announces end of patient treatment for phase III ibalizumab trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.